PubMed=6572752; DOI=10.1093/jnci/70.4.649
Whitehead R.H., Bertoncello I., Webber L.M., Pedersen J.S.
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization.
J. Natl. Cancer Inst. 70:649-661(1983)

PubMed=6606728; DOI=10.1093/jnci/71.6.1193
Whitehead R.H., Monaghan P., Webber L.M., Bertoncello I., Vitali A.A.
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. II. Characterization of cells growing as organoids.
J. Natl. Cancer Inst. 71:1193-1203(1983)

PubMed=6381852; DOI=10.1093/jnci/73.3.643
Whitehead R.H., Quirk S.J., Vitali A.A., Funder J.W., Sutherland R.L., Murphy L.C.
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness.
J. Natl. Cancer Inst. 73:643-648(1984)

PubMed=2228321; DOI=10.1002/ijc.2910460531
Monaghan P., Ormerod M.G., O'Hare M.J.
Epidermal growth factor receptors and EGF-responsiveness of the human breast-carcinoma cell line PMC42.
Int. J. Cancer 46:935-943(1990)

DOI=10.1016/B978-0-12-333530-2.50009-5
Leibovitz A.
Cell lines from human breast.
(In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York; USA (1994)

PubMed=11044355; DOI=10.1054/bjoc.2000.1458; PMCID=PMC2408781
Davidson J.M., Gorringe K.L., Chin S.-F., Orsetti B., Besret C., Courtay-Cahen C., Roberts I., Theillet C., Caldas C., Edwards P.A.W.
Molecular cytogenetic analysis of breast cancer cell lines.
Br. J. Cancer 83:1309-1317(2000)

PubMed=11161701; DOI=10.1006/excr.2000.5106
Ackland M.L., Michalczyk A., Whitehead R.H.
PMC42, a novel model for the differentiated human breast.
Exp. Cell Res. 263:14-22(2001)

DOI=10.25904/1912/1434
Morrison B.J.
Breast cancer stem cells: tumourspheres and implications for therapy.
Thesis PhD (2010); Griffith University; Brisbane; Australia

PubMed=24176112; DOI=10.1186/gb-2013-14-10-r110; PMCID=PMC3937590
Daemen A., Griffith O.L., Heiser L.M., Wang N.J., Enache O.M., Sanborn Z., Pepin F., Durinck S., Korkola J.E., Griffith M., Hur J.S., Huh N., Chung J., Cope L., Fackler M.J., Umbricht C.B., Sukumar S., Seth P., Sukhatme V.P., Jakkula L.R., Lu Y.-L., Mills G.B., Cho R.J., Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.
Modeling precision treatment of breast cancer.
Genome Biol. 14:R110.1-R110.14(2013)

PubMed=28889351; DOI=10.1007/s10549-017-4496-x
Saunus J.M., Smart C.E., Kutasovic J.R., Johnston R.L., Kalita-de Croft P., Miranda M., Rozali E.N., Vargas A.C., Reid L.E., Lorsy E., Cocciardi S., Seidens T., McCart Reed A.E., Dalley A.J., Wockner L.F., Johnson J., Sarkar D., Askarian-Amiri M.E., Simpson P.T., Khanna K.K., Chenevix-Trench G., Al-Ejeh F., Lakhani S.R.
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
Breast Cancer Res. Treat. 167:289-301(2018)